Nanopolyphenols: a review of their encapsulation and anti-diabetic effects

• Published in: SN applied sciences Vol. 2; no. 8; pp. 1335 - 26
• Main Author: Rambaran, Theresa F.
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.08.2020; Springer Nature B.V; Springer
• Subjects: Acids; Applied and Technical Physics; Bioavailability; Chemistry/Food Science; Chemistry: Pharmaceutical; Clinical trials; Curcumin; Diabetes; Diabetes mellitus; Diet; Drug delivery; Drug delivery systems; Earth Sciences; Effectiveness; Encapsulation; Engineering; Environment; Flavonoids; Free form; Functional foods & nutraceuticals; Glucose; Insulin; Materials Science; Medical; Medicinal and Clinical Chemistry; Nanocarrier; Nanoencapsulation; Nanomaterials; Nanomedicine; Nanoparticles; Nanopolyphenols; Oral administration; Pharmacology; Phase transitions; Phenolic acids; Phenols; Polymers; Polyphenols; Quercetin; Review Paper; Nanopolyphenols; Nanocarrier; Diabetes; Nanoencapsulation; Nanomedicine
• ISSN: 2523-3963; 2523-3971; 2523-3971
• DOI: 10.1007/s42452-020-3110-8

Polyphenols are believed to possess numerous health benefits and can be grouped as phenolic acids, flavonoids or non-flavonoids. Research involving the synthesis of nanopolyphenols has attracted interest in the areas of functional food, nutraceutical and pharmaceutical development. This is in an effort to overcome current challenges which limit the application of polyphenols such as their rapid elimination, low water-solubility, instability at low pH, and their particle size. In the synthesis of nanopolyphenols, the type of nanocarrier used, the nanoencapsulation technique employed and the type of polymers that constitute the drug delivery system are crucial. For this review, all mentioned factors which can influence the therapeutic efficacy of nanopolyphenols were assessed. Their efficacy as anti-diabetic agents was also evaluated in 33 publications. Among these were phenolic acid (1), flavonoids (13), non-flavonoids (17) and polyphenol-rich extracts (2). The most researched polyphenols were quercetin and curcumin. Nanoparticles were the main nanocarrier and the size of the nanopolyphenols ranged from 15 to 333 nm with encapsulation efficiency and drug loading capacities of 56–97.7% and 4.2–53.2%, respectively. The quantity of nanomaterial administered orally ranged from 1 to 300 mg/kg/day with study durations of 1–70 days. Most studies compared the effect of the nanopolyphenol to its free-form and, in all but three cases, significantly greater effects of the former were reported. Assessment of the polyphenol to understand its properties and the subsequent synthesis of its nanoencapsulated form using suitable nanocarriers, polymers and encapsulation techniques can result in effective therapeutic agents for the treatment of diabetes.